At the present time, there are no biodegradable stents available for use in pediatric patients with congenital heart disease, despite this population being most likely to benefit from a technology that will eventually disappear enabling all future treatment options and potentially future vessel growth. Current research is focused on identifying optimal biodegradable material and stent design to develop larger diameter stents with reasonable profile and strength to sustain the larger pulmonary arteries and aortic obstruction. In this article, we review the challenges faced with fabricating a larger diameter biodegradable stent and the currently available biodegradable scaffolds made for coronary and peripheral artery interventions and provide a summary of the current biodegradable stents being assessed for congenital heart disease applications.
- Biodegradable stents
- Bioresorbable polymers
- Congenital heart disease
- Pediatric stents
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Pediatrics, Perinatology, and Child Health